Ischemic Preconditioning in Endurance Athletes
Not Applicable
Completed
- Conditions
- Exercise
- Registration Number
- NCT01774461
- Lead Sponsor
- Maastricht University Medical Center
- Brief Summary
The aim of this study is to investigate the effect of remote ischemic preconditioning on biochemical and functional indices of cardiac function induced by a 30 km run in healthy trained long distance runners.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 29
Inclusion Criteria
- Informed consent
- Healthy
- Age between 18 and 65 years
- Endurance-trained (two or more training sessions per week)
Exclusion Criteria
- Not applicable
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- CROSSOVER
- Primary Outcome Measures
Name Time Method Serum concentrations of cardiac troponins 6 hours, 2 hourly time intervals
- Secondary Outcome Measures
Name Time Method Indices of cardiac function measured by echocardiography 2 hours post-exercise
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular pathways mediate RIPC-induced cardioprotection in endurance athletes post-30 km run?
How does RIPC compare to standard recovery protocols in mitigating cardiac biomarker elevation after prolonged exercise?
Which biomarkers correlate with RIPC efficacy in trained athletes during high-intensity endurance events?
What are the potential adverse effects of RIPC in healthy athletes and their management strategies?
How does RIPC's mechanism align with pharmacological preconditioning agents in preventing exercise-induced cardiac stress?
Trial Locations
- Locations (1)
Maastricht University Medical Center
🇳🇱Maastricht, Netherlands
Maastricht University Medical Center🇳🇱Maastricht, Netherlands